ETHNIC-DIFFERENCES IN THE CLINICAL AND LABORATORY ASSOCIATIONS WITH RETINOPATHY IN ADULT-ONSET DIABETES - STUDIES IN PATIENTS OF AFRICAN, EUROPEAN AND INDIAN ORIGINS
Wj. Kalk et al., ETHNIC-DIFFERENCES IN THE CLINICAL AND LABORATORY ASSOCIATIONS WITH RETINOPATHY IN ADULT-ONSET DIABETES - STUDIES IN PATIENTS OF AFRICAN, EUROPEAN AND INDIAN ORIGINS, Journal of internal medicine, 241(1), 1997, pp. 31-37
Objective. To evaluate the prevalence of diabetic retinopathy (DR) and
its associations in adult onset diabetic patients of African, Europea
n and Indian origins. Design. The prevalence of retinopathy was determ
ined by 60 degrees retinal photography in 507 consecutive out-patients
. Clinical and laboratory associations were evaluated. Setting. Diabet
es clinic in a large community hospital. Main outcome measures. The as
sociations between clinical and laboratory measurements with retinopat
hy. Results. African patients (A) had shorter duration of diabetes (P
< 0.001), higher HbA1 levels (P < 0.01) compared to those of Europeans
(E) and Indian (I) extraction. A also had lower C-peptide levels (med
ian 0.57 nmol L(-1); vs. E, 0.81 nmol L(-1) and I, 0.93 nmol L(-1)) (P
< 0.001). The prevalences of retinopathy at diagnosis (21-25%) and ov
erall were similar (A 37%, E 41%, I 37%). Severe DR was more frequent
in the Africans (52%, P < 0.0001) and Indians (41%, P = 0.03) compared
to the Europeans (26%). In Africans DR was significantly associated o
nly with duration of diabetes (P < 0.0001) and macro-albuminuria (P =
0.01); in I it was also associated with systolic BP (P = 0.03); in E a
lso with lower C-peptide levels (P = 0.0002), worse glycaemic control
and greater use of insulin (P < 0.0001). In patients with DR insulin w
as used less frequently in A (35%) than in E patients (62%) (P = 0.001
). Conclusions. In South Africa, the African population with adult ons
et diabetes has the highest prevalence of severe retinopathy, probably
the result of very poor glycaemic control attributable to more severe
insulinopenia and infrequent insulin treatment. Visual loss from diab
etic retinopathy is likely to be considerable in Africans.